Health news round up: long-term conditions, cancer drugs and a medicines pricing stand-off Senior clinical reporter Joanna Robertson summarises some important developments in health news.…
Patients with head and neck cancer to be fast-tracked into NHS vaccine trial The investigational mRNA cancer vaccine will be trialled across 15 NHS hospitals over 12 months, the third cancer vaccine trial to be run through the NHS Cancer Vaccine Launch Pad.…
Immunotherapy plus chemotherapy approved for endometrial cancer Immunotherapy drug pembrolizumab (Keytruda: Merck Sharp and Dohme) could benefit 2,100 people with advanced womb cancer.…
NICE recommends ‘breakthrough’ therapy for blood cancer Belantamab mafodotin combination therapy is a second-line treatment option for multiple myeloma that could benefit around 1,500 people.…
NICE recommends capivasertib for advanced breast cancer Clinical trial results revealed that capivasertib, taken with fulvestrant, can provide advanced breast cancer patients with an additional four months before their cancer progresses.…
NICE recommends olaparib for advanced breast cancer in final draft guidance The drug has previously been recommended for some types of ovarian cancer in England and for prostate cancer in Scotland.…
CAR-T infusions delivered to ‘more than 80’ patients in Wales, says NHS Wales The NHS Wales Joint Commissioning Committee has enabled 100 patients in Wales to receive an advanced therapy medicinal product to date.…
Lung cancer: screening, diagnosis and management An overview of the symptoms of suspected lung cancer, treatment strategies and current national screening programmes and pilots.…
Thousands of NHS patients with prostate or breast cancer eligible for new targeted treatment NHS England says around 800 people in England could be eligible for olaparib treatment each year.…
NHS patients will be first in Europe to receive mutation-targeting lung cancer treatment The tumour-agnostic drug sotorasib has been approved for the treatment of patients in England with non-small cell lung cancer.…
